Xinzhi Li

ORCID: 0000-0003-1549-3437
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Fatty Acid Research and Health
  • Nutritional Studies and Diet
  • Flavonoids in Medical Research
  • Eicosanoids and Hypertension Pharmacology
  • Nanoplatforms for cancer theranostics
  • Angiogenesis and VEGF in Cancer
  • Quantum optics and atomic interactions
  • Natural product bioactivities and synthesis
  • Cancer, Lipids, and Metabolism
  • Extracellular vesicles in disease
  • Atomic and Subatomic Physics Research
  • Obesity, Physical Activity, Diet
  • Plant-derived Lignans Synthesis and Bioactivity
  • Phytochemistry and Biological Activities
  • Climate Change and Health Impacts
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Advanced MRI Techniques and Applications

Shihezi University
2024-2025

Macau University of Science and Technology
2022-2023

Ischemic stroke (IS) constitutes the leading cause of global morbidity and mortality. Neuroprotectants are essential to ameliorate clinical prognosis, but their therapeutic outcomes tremendously compromised by insufficient delivery ischemic lesion intricate pathogenesis associated with neuronal damage, oxidative stress, inflammation responses, blood-brain barrier (BBB) dysfunction, etc. Herein, a biomimetic nanosystem (Leo@NM-Lipo) composed neutrophil membrane-fused nanoliposomal leonurine...

10.1016/j.mtbio.2023.100674 article EN cc-by-nc-nd Materials Today Bio 2023-05-19

Vascular remodeling is a critical independent risk factor contributing to the increased incidence of cardiovascular events in hypertensive patients. Apigenin plays pivotal role hypertension protection. However, its impact on hypertension-induced vascular remains underexplored. This study investigates protective effects and underlying mechanisms apigenin hypertension. In vivo experiments demonstrated that attenuated aortic spontaneously rats (SHRs). Treatment with resulted reduction...

10.1016/j.intimp.2025.114706 article EN cc-by-nc-nd International Immunopharmacology 2025-05-02

Doxorubicin (Dox) is widely utilized in the clinical treatment of various cancers. Despite its efficacy, Dox induces numerous adverse effects humans with significant cardiotoxicity, posing a major limitation to use.

10.3724/abbs.2024170 article EN cc-by-nc-nd Acta Biochimica et Biophysica Sinica 2024-09-19
Coming Soon ...